Skip to main content
. 2021 Jun 18;26(10):e1854–e1861. doi: 10.1002/onco.13851

Table 4.

Patient‐reported severity of dexamethasone‐related side effects

Side effect NEPA + DEX1 n (%) NEPA + DEX3 n (%) NEPA + DEX4 n (%)
Indigestion/heartburn or reflux (n = 74) (n = 74) (n = 74)
Not at all 36 (48.6) 33 (44.6) 38 (51.4)
A little bit 17 (23.0) 16 (21.6) 17 (23.0)
Quite a bit 10 (13.5) 16 (21.6) 14 (18.9)
Very much 11 (14.9) 9 (12.2) 5 (6.8)
Insomnia (n = 75) (n = 74) (n = 75)
Not at all 43 (57.3) 38 (51.4) 35 (46.7)
A little bit 19 (25.3) 17 (23.0) 21 (28.0)
Quite a bit 8 (10.7) 13 (17.6) 16 (21.3)
Very much 5 (6.7) 6 (8.1) 3 (4.0)
Hiccups (n = 75) (n = 74) (n = 75)
Not at all 52 (69.3) 46 (62.2) 43 (57.3)
A little bit 12 (16.0) 22 (29.7) 16 (21.3)
Quite a bit 9 (12.0) 4 (5.4) 10 (13.3)
Very much 2 (2.7) 2 (2.7) 6 (8.1)
Agitation (n = 75) (n = 74) (n = 75)
Not at all 40 (53.3) 37 (50.0) 34 (45.3)
A little bit 21 (28.0) 14 (18.9) 26 (34.7)
Quite a bit 11 (14.7) 19 (25.7) 14 (18.7)
Very much 3 (4.0) 4 (5.4) 1 (1.3)
Facial rash/ acne (n = 75) (n = 74) (n = 75)
Not at all 70 (93.3) 61 (82.4) 69 (92.1)
A little bit 5 (6.7) 8 (10.8) 4 (5.3)
Quite a bit 0 4 (5.4) 1 (1.3)
Very much 0 1 (1.4) 1 (1.3)

Abbreviations: DEX1, dexamethasone day 1; DEX3, dexamethasone day 1 to 3; DEX4, dexamethasone day 1 to 4; NEPA, fixed‐dose combination of netupitant and palonosetron.